Georgia Cancer Center
Georgia Cancer Center is an academic cancer research and treatment facility within Augusta University that delivers precision medicine, immunotherapy, and clinical trials to Southeast US patients while training medical students and residents through the Medical College of Georgia.
- Company typePrivate
- Founded1828
- HeadquartersAugusta, United States
- Headcount5,001–10,000
- GTM typeB2C
- OfferingServices
What Georgia Cancer Center does
The Georgia Cancer Center is an academic cancer research and clinical care facility operating as a department within Augusta University, a public state university in Augusta, Georgia. It conducts cancer research across genome mapping, immunotherapy, and CAR-T cell therapy development, while delivering precision medicine and clinical trial access to patients in the Southeast US. The center is integrated with the Medical College of Georgia (founded 1828), which trains roughly 304 students per class — the fourth largest medical school class size nationally — and supports nearly 600 residents and fellows across 51 ACGME-approved programs.
Its business model combines three revenue streams: federal and philanthropic research funding (e.g., a $2.3M NCI grant for AML research in April 2023, with MCG reporting $117M in total research grants and contracts), clinical service revenue through the Wellstar MCG Health hospital system and a statewide network of approximately 100 physician faculty clinics, and institutional appropriations from the University System of Georgia. Specific procedure pricing is not publicly disclosed, with clinical services reimbursed through insurance, Medicare, and Medicaid.
The center serves three primary constituencies: cancer patients receiving treatment and clinical trial access, medical students and residents pursuing education across four-year campuses in Augusta, Athens (University of Georgia partnership), and Savannah (Georgia Southern University partnership), and researchers/physician scientists advancing translational oncology. Marketing and community engagement flow through Jagwire news, an event calendar, and an active social media presence on Facebook, X, LinkedIn, YouTube, and Instagram.
Georgia Cancer Center firmographics
Firmographics- Name
- Georgia Cancer Center
- Legal name
- Georgia Cancer Center
- Website
- https://augusta.edu
- Company type
- Private
- Founded year
- 1828
- Operating status
- Operating
- Headcount range
- 5,001–10,000 employees
- Short description
- Georgia Cancer Center is an academic cancer research and treatment facility within Augusta University that delivers precision medicine, immunotherapy, and clinical trials to Southeast US patients while training medical students and residents through the Medical College of Georgia.
- Ownership category
- akta.pro rank
Georgia Cancer Center industry classification
Industry- Product category
- Academic Cancer Treatment Services
- NAICS
- Specialty (except Psychiatric and Substance Abuse) Hospitals (622310), Ambulatory Health Care Services (621)
- SIC
- Services-Health Services (8000), Services-Offices & Clinics Of Doctors Of Medicine (8011), Services-Specialty Outpatient Facilities, Nec (8093)
- akta.pro primary industry
- Oncology & Cancer Specialty Hospitals (HLAFAHAC)
- akta.pro secondary industries
- Ambulatory Oncology Centers (Outpatient Chemo/Radiation) (HLAFABAI), Medical Oncology (HLAKAFAB), Cell Therapy Clinical Services & Treatment Centers (apheresis, administration, monitoring) (HLAAABAJ)
Keywords
Where Georgia Cancer Center is headquartered
LocationHeadquarters
- HQ city
- Augusta
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
Georgia Cancer Center business model
Business model- GTM type
- B2C
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales
Distribution channels3 records
Marketing channels3 records
Georgia Cancer Center product offering
Product offeringCore offering
The Georgia Cancer Center at Augusta University is an academic cancer research and clinical care facility that delivers cancer treatment, prevention, and scientific discovery services. It provides patient care, clinical trials, immunotherapy, and precision medicine, while conducting cancer research programs including acute myeloid leukemia (AML) research funded by the National Cancer Institute, and serves as a training site for medical students and residents.
Product overview
The Georgia Cancer Center at Augusta University is a research and clinical care facility focused on cancer treatment, prevention, and scientific discovery. It operates as part of the Medical College of Georgia, offering patient care services, clinical trials, and cancer research programs aimed at improving survival rates for various cancers including acute myeloid leukemia (AML).
Differentiator
Problem solved
Functional benefit
Products and services
- Cancer Treatment and Patient Care Services
Quantifiable outcome
- Higher than national average Match rate for medical students
- +1 more outcomes
Companies that use Georgia Cancer Center
Customer profileSegments3 records
Ideal customer profiles3 records
Georgia Cancer Center technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature1 record
Georgia Cancer Center partnerships and signals
Strategic signalPartnerships
Four partnerships are on record, tiered core.
- Clark Atlanta UniversitycorePartner in Southeastern VICEROY Cyber Institute created under the John S. McCain National Defense Authorization Act to accelerate development of critical cyber operational skills. Partnership established after receiving a $2 million award for cyber education and workforce development.
- Mississippi State UniversitycorePartner in Southeastern VICEROY Cyber Institute created under the John S. McCain National Defense Authorization Act to accelerate development of critical cyber operational skills. Partnership established after receiving a $2 million award for cyber education and workforce development.
- University of GeorgiacorePartnership to operate a four-year medical campus in Athens, Georgia. MCG's statewide educational model includes this campus to offer students experience across the full spectrum of medicine.
- Georgia Southern UniversitycorePartnership to operate a four-year medical campus in Savannah, Georgia. MCG's statewide educational model includes this campus to expand medical education access across Georgia.
Scale indicators6 records
Recent moves6 records
Expansion highlights5 records
Georgia Cancer Center competitors and assessment
Company assessmentDirect peers
- Moffitt Cancer Center: NCI-designated Comprehensive Cancer Center in Tampa with similar mid-tier academic profile, strong focus on immunotherapy and personalized medicine, and a comparable operating model combining research, clinical care, and education.
- Duke Cancer Institute: NCI-designated Comprehensive Cancer Center integrated within Duke University Health System, offering academic clinical care, translational research, and oncology training directly comparable to Georgia Cancer Center's academic medical center model.
- Roswell Park Comprehensive Cancer Center: NCI-designated Comprehensive Cancer Center in Buffalo, NY and one of the oldest academic cancer centers in the US; comparable in combining inpatient specialty oncology care, research, and training across hematologic and solid tumor programs.
- Memorial Sloan Kettering Cancer Center: One of the largest academic cancer centers globally, providing integrated clinical care, research, and fellowship training across all oncology subspecialties; the high-end reference point for academic cancer center operating models.
- O'Neal Comprehensive Cancer Center at UAB: NCI-designated Comprehensive Cancer Center at the University of Alabama at Birmingham; comparable in scale and Southeast US positioning, with overlapping research strengths in cancer disparities, immunotherapy, and population catchment.
- Winship Cancer Institute at Emory University: Georgia's only NCI-designated Comprehensive Cancer Center and the most directly comparable peer, operating as an academic cancer center at Emory University with overlapping research focus in cancer immunology, cell therapy, and clinical trials serving the same regional patient population.
- Fred Hutchinson Cancer Center: NCI-designated Comprehensive Cancer Center in Seattle, recognized for pioneering work in bone marrow transplantation, immunotherapy, and cell therapy research that overlaps directly with Georgia Cancer Center's CAR-T and AML research focus.
- Dana-Farber Cancer Institute: Harvard-affiliated academic cancer center recognized for translational research and clinical trials in hematologic malignancies (including AML) and solid tumors; directly comparable research portfolio in CAR-T, immunotherapy, and precision oncology.
- MD Anderson Cancer Center: The benchmark NCI-designated Comprehensive Cancer Center; comparable in offering clinical care, translational research, and fellowship/residency training, and serves as the aspirational peer for academic cancer centers pursuing higher NCI designation tiers.
- Hollings Cancer Center at MUSC: NCI-designated cancer center at the Medical University of South Carolina; comparable Southeast regional academic cancer center pursuing Comprehensive Cancer Center status with similar research and clinical trial focus areas.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks5 records
Key highlights7 records
Customer concentration
Georgia Cancer Center social profiles
Digital presenceGeorgia Cancer Center financial estimates
Financial estimateRevenue estimate
Valuation estimate
Georgia Cancer Center leadership team
Management profileNumber of profiles
Profiles1 record
Georgia Cancer Center funding detail
Funding detailFunding overview
Funding rounds1 record
Investors1 record
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Georgia Cancer Center M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Georgia Cancer Center
What does Georgia Cancer Center do?
The Georgia Cancer Center at Augusta University is an academic cancer research and clinical care facility that delivers cancer treatment, prevention, and scientific discovery services. It provides patient care, clinical trials, immunotherapy, and precision medicine, while conducting cancer research programs including acute myeloid leukemia (AML) research funded by the National Cancer Institute, and serves as a training site for medical students and residents.
Is Georgia Cancer Center a public or private company?
Georgia Cancer Center is a private company. It is classified as state government owned and is currently operating.
When was Georgia Cancer Center founded?
Georgia Cancer Center was founded in 1828. It employs 5,001 to 10,000 people.
Where is Georgia Cancer Center based?
Georgia Cancer Center is headquartered in Augusta, United States, in the North America region.
Who are Georgia Cancer Center's main competitors?
Direct peers on record are Moffitt Cancer Center, Duke Cancer Institute, Roswell Park Comprehensive Cancer Center, Memorial Sloan Kettering Cancer Center, O'Neal Comprehensive Cancer Center at UAB, Winship Cancer Institute at Emory University, Fred Hutchinson Cancer Center, Dana-Farber Cancer Institute, MD Anderson Cancer Center and Hollings Cancer Center at MUSC.
Does Georgia Cancer Center have an API?
No public API is recorded for Georgia Cancer Center.
What industry is Georgia Cancer Center in?
Georgia Cancer Center's product category is Academic Cancer Treatment Services. Its primary akta.pro industry code is HLAFAHAC, Oncology & Cancer Specialty Hospitals, with a secondary code of HLAFABAI, Ambulatory Oncology Centers (Outpatient Chemo/Radiation). Its NAICS code is 622310 and its SIC code is 8000.